Gammy it just gets tiring when people incessantly question companies strategies, having little knowledge themselves of the validity of their criticisms. Not that I'm accusing you of that - reading some of the other KAI threads you come across as pretty well informed so I'll give you the benefit of the doubt.
Maybe just have a little more faith they doing the right thing, in as timely a fashion as the busy Pilbara field season allows
- Forums
- ASX - By Stock
- Ann next week!?
Gammy it just gets tiring when people incessantly question...
Featured News
Add KAI (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.20M |
Open | High | Low | Value | Volume |
1.0¢ | 1.1¢ | 0.9¢ | $95.11K | 9.506M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1199999 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 2439974 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1199999 | 0.010 |
21 | 7489678 | 0.009 |
23 | 4040327 | 0.008 |
6 | 2242977 | 0.007 |
6 | 6723888 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 2439974 | 8 |
0.012 | 6019878 | 6 |
0.013 | 2766703 | 8 |
0.014 | 3240595 | 7 |
0.015 | 1885431 | 8 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
KAI (ASX) Chart |